Day One Biopharmaceuticals, Inc. (DAWN)
USD 7.11
(-7.78%)
USD 7.11
(-7.78%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -230.37 Million USD | -172.8% |
| 2022 | -84.44 Million USD | 70.27% |
| 2021 | -284.08 Million USD | -555.7% |
| 2020 | -43.32 Million USD | -58.52% |
| 2019 | -27.33 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -239.42 Million USD | 11.35% |
| 2024 Q1 | -270.09 Million USD | -17.24% |
| 2024 Q3 | -420.15 Million USD | -75.48% |
| 2023 Q2 | -188.59 Million USD | -288.44% |
| 2023 Q4 | -230.37 Million USD | 4.28% |
| 2023 FY | -230.37 Million USD | -172.8% |
| 2023 Q3 | -240.66 Million USD | -27.61% |
| 2023 Q1 | -48.55 Million USD | 42.51% |
| 2022 Q3 | -119.88 Million USD | 69.09% |
| 2022 FY | -84.44 Million USD | 70.27% |
| 2022 Q4 | -84.44 Million USD | 29.56% |
| 2022 Q2 | -387.83 Million USD | -47.71% |
| 2022 Q1 | -262.56 Million USD | 7.58% |
| 2021 Q2 | -309.68 Million USD | -100.43% |
| 2021 FY | -284.08 Million USD | -555.7% |
| 2021 Q1 | -154.51 Million USD | -256.63% |
| 2021 Q4 | -284.08 Million USD | 4.31% |
| 2021 Q3 | -296.89 Million USD | 4.13% |
| 2020 FY | -43.32 Million USD | -58.52% |
| 2020 Q4 | -43.32 Million USD | 0.0% |
| 2019 FY | -27.33 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -311.827% |
| Alkermes plc | -166.73 Million USD | -38.166% |
| Agenus Inc. | 274.13 Million USD | 184.037% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 112.32% |
| Aptorum Group Limited | 1.35 Million USD | 17076.285% |
| Ardelyx, Inc. | 34.51 Million USD | 767.524% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 5482.617% |
| Bicycle Therapeutics plc | -481.46 Million USD | 52.151% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 737.049% |
| ChromaDex Corporation | -24.04 Million USD | -857.984% |
| Chimerix, Inc. | -25.51 Million USD | -802.833% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 3406.164% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -872.995% |
| CRISPR Therapeutics AG | -150.84 Million USD | -52.724% |
| Precision BioSciences, Inc. | -85.41 Million USD | -169.73% |
| Dyadic International, Inc. | -6.37 Million USD | -3511.985% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1345.905% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3105.558% |
| Lantern Pharma Inc. | -21.7 Million USD | -961.48% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -108.415% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2596.608% |
| Incyte Corporation | -3.17 Billion USD | 92.744% |
| IO Biotech, Inc. | -140.69 Million USD | -63.737% |
| Jaguar Health, Inc. | 29.39 Million USD | 883.832% |
| Novavax, Inc. | -298.29 Million USD | 22.769% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 4416.582% |
| Opthea Limited | 28.15 Million USD | 918.171% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1272.184% |
| ContextLogic Inc. | -232 Million USD | 0.7% |
| MiMedx Group, Inc. | -33.9 Million USD | -579.555% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 2359.696% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -9842.741% |
| NextCure, Inc. | -6.47 Million USD | -3456.832% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -356.181% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -3511.475% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1994.031% |
| Vaxcyte, Inc. | -368.22 Million USD | 37.436% |
| PDS Biotechnology Corporation | -32.7 Million USD | -604.322% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1433.349% |
| Pharming Group N.V. | 109.8 Million USD | 309.807% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1224.304% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -31.471% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1143.941% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1143.941% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -3144.732% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -3831.331% |
| Acelyrin, Inc. | -216.9 Million USD | -6.212% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -4006.329% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -13262.877% |
| Summit Therapeutics Inc. | 34.67 Million USD | 764.406% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -3286.388% |
| Senti Biosciences, Inc. | 1.74 Million USD | 13340.0% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -24.793% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -197.447% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -3700.33% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 231009.401% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 36784.076% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -96.825% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -36.939% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 307.789% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2932.859% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -78.428% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 3441.399% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 4.946% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1215.698% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 27.258% |
| MEI Pharma, Inc. | -3.7 Million USD | -6117.976% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1941.388% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 242.434% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 928.899% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3105.558% |
| Precigen, Inc. | -481 Thousand USD | -47795.218% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1736.077% |
| AlloVir, Inc. | -62.69 Million USD | -267.473% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -314.241% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 473.587% |
| ImmuCell Corporation | 10.99 Million USD | 2196.126% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -49.453% |
| Onconetix, Inc. | 5.33 Million USD | 4421.086% |
| PureTech Health plc | -167.19 Million USD | -37.787% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -656.323% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1105.021% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -4592.931% |
| Seer, Inc. | -4.24 Million USD | -5333.396% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -858.422% |
| Innoviva, Inc. | 255.56 Million USD | 190.145% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -312.387% |
| ESSA Pharma Inc. | -33.62 Million USD | -585.203% |
| GlycoMimetics, Inc. | -40.98 Million USD | -462.106% |
| GT Biopharma, Inc. | -1.02 Million USD | -22463.761% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -239.873% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 476.081% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -71.821% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1562.644% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -697.922% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -305706.143% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -646.471% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2711.227% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -7262.566% |
| Soligenix, Inc. | -4.95 Million USD | -4552.56% |
| Century Therapeutics, Inc. | 847 Thousand USD | 27299.055% |
| Kura Oncology, Inc. | -20.11 Million USD | -1045.124% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -462.909% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2643.225% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 12746.244% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -7106.006% |
| Autolus Therapeutics plc | -186.59 Million USD | -23.46% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -367.256% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 16.468% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 772.277% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 240.159% |
| GRI Bio, Inc. | -1.79 Million USD | -12741.472% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2464.564% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -592.714% |
| IGM Biosciences, Inc. | -72.6 Million USD | -217.296% |
| INmune Bio, Inc. | -25.41 Million USD | -806.6% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 252.616% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -354.758% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1317.753% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -7885.508% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 706.013% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -459.369% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 822.522% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 160.954% |
| Verastem, Inc. | -37.27 Million USD | -517.995% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2439.138% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -344.21% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1422.141% |
| Histogen Inc. | -7.48 Million USD | -2977.013% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -966.219% |
| Surrozen, Inc. | -32.66 Million USD | -605.29% |
| Organovo Holdings, Inc. | -1.5 Million USD | -15187.06% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -5380.591% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1315.05% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 8906.422% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 5643.215% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2648.74% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -430.307% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1480.423% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 27.278% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -31805.382% |
| Apollomics, Inc. | -27.39 Million USD | -740.942% |
| Amarin Corporation plc | -191.04 Million USD | -20.59% |
| Mesoblast Limited | 55.96 Million USD | 511.658% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1479.649% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -810.865% |
| Synaptogenix, Inc. | -28.66 Million USD | -703.782% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -24512.821% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 572.741% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -26622.995% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -3070.568% |
| Exelixis, Inc. | -73.05 Million USD | -215.368% |
| Better Therapeutics, Inc. | -860 Thousand USD | -26687.907% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -859.38% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 4.555% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 31398.28% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2997.228% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 18471.292% |
| Gritstone bio, Inc. | 39.49 Million USD | 683.378% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -173.928% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -8652.422% |
| Avid Bioservices, Inc. | 169.72 Million USD | 235.732% |
| Insmed Incorporated | 721.62 Million USD | 131.925% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -2420.108% |
| MediWound Ltd. | -5.32 Million USD | -4228.749% |
| OmniAb, Inc. | 9.2 Million USD | 2603.271% |
| Alector, Inc. | -35.63 Million USD | -546.452% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 367.969% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -4574.838% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1840.131% |
| Zai Lab Limited | -775 Million USD | 70.274% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 167.647% |
| Aura Biosciences, Inc. | -21.52 Million USD | -970.272% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -179.311% |
| Immunic, Inc. | -45.34 Million USD | -408.108% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -19.233% |
| Veracyte, Inc. | -203.82 Million USD | -13.027% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 136.092% |
| FibroGen, Inc. | 56.76 Million USD | 505.827% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2687.041% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -8048.897% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -11027.405% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 105.019% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -6795.421% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -38.811% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1389.755% |
| Galecto, Inc. | -21.21 Million USD | -985.86% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -868.577% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 114.679% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -841.386% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1902.051% |
| XBiotech Inc. | -200.02 Million USD | -15.175% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -173.928% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 5187.809% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -553.308% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -198.345% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 4148.076% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -35.185% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -149.395% |
| Vaxxinity, Inc. | 10.13 Million USD | 2373.747% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 131.29% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -2039.539% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -249.287% |
| NexImmune, Inc. | -3.13 Million USD | -7251.699% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -6572.396% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1424.513% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -750.096% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2466.562% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -184829.561% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -467.82% |
| Ainos, Inc. | 4.07 Million USD | 5749.34% |
| Pluri Inc. | 22.82 Million USD | 1109.138% |
| Prothena Corporation plc | -608.34 Million USD | 62.131% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -93.991% |
| Celularity Inc. | 65.19 Million USD | 453.392% |
| Rallybio Corporation | -24.1 Million USD | -855.838% |
| Cue Biopharma, Inc. | -33.81 Million USD | -581.203% |
| MeiraGTx Holdings plc | -40.3 Million USD | -471.624% |
| Omeros Corporation | 331.17 Million USD | 169.563% |
| Humacyte, Inc. | -22.48 Million USD | -924.531% |
| Immunocore Holdings plc | -358.59 Million USD | 35.756% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -837.44% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -645.529% |
| Blueprint Medicines Corporation | 702.83 Million USD | 132.778% |
| CalciMedica, Inc. | -5.53 Million USD | -4065.931% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -22.397% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -2155.492% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -475.408% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -592.798% |
| Pulmatrix, Inc. | -10.41 Million USD | -2111.539% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -3754.375% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -503.996% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -106.797% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -284.319% |
| Cytokinetics, Incorporated | 642.37 Million USD | 135.863% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -3856.311% |
| Nutriband Inc. | -251.65 Thousand USD | -91443.649% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -575.213% |
| Vor Biopharma Inc. | 4.3 Million USD | 5457.581% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 96.183% |
| Evogene Ltd. | -19.63 Million USD | -1073.352% |
| ProKidney Corp. | -56.23 Million USD | -309.659% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -373.323% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -2394.006% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 116.891% |
| CorMedix Inc. | -43.05 Million USD | -435.105% |
| BioLineRx Ltd. | 7.33 Million USD | 3240.349% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -738.798% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 599.222% |
| Atai Life Sciences N.V. | -28.55 Million USD | -706.695% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 10428.312% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -909.712% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1398.991% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -206.865% |
| MediciNova, Inc. | -50.78 Million USD | -353.643% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -192.337% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1024020.916% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3470.288% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -15.291% |
| Biomea Fusion, Inc. | -166.57 Million USD | -38.306% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -28.72% |
| Mereo BioPharma Group plc | -51.46 Million USD | -347.601% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -142.9% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 21.577% |
| Absci Corporation | -72.59 Million USD | -217.331% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 5145.466% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 1.732% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -144.532% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -140.737% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -489.604% |
| Allakos Inc. | -24.97 Million USD | -822.426% |
| Imunon, Inc. | -4.21 Million USD | -5367.112% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1462.719% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -70.145% |
| BioAtla, Inc. | -109.01 Million USD | -111.333% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 31398.28% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -24434.185% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 2025.255% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -986.525% |
| XOMA Corporation | -29 Million USD | -694.4% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1291.159% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2455.191% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2992.71% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -84.839% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -10.67% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -181.706% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -148.349% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -26713.348% |
| Akari Therapeutics, Plc | -3.84 Million USD | -5891.573% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 14295.417% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 116.683% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -19289.716% |
| UroGen Pharma Ltd. | 4.39 Million USD | 5346.55% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 303.008% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 320235.627% |
| Orgenesis Inc. | 21.78 Million USD | 1157.547% |
| Entera Bio Ltd. | -10.62 Million USD | -2067.429% |
| GH Research PLC | -78.07 Million USD | -195.063% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -933.632% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -764.158% |
| Xencor, Inc. | 29.64 Million USD | 877.142% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -11595.329% |
| Replimune Group, Inc. | 1.41 Million USD | 16415.581% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -93966.343% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -82.235% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -19289.716% |
| Portage Biotech Inc. | -4.98 Million USD | -4525.095% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1024020.916% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -248.411% |
| OncoCyte Corporation | -6.56 Million USD | -3410.224% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 25771.124% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -4956.937% |
| Purple Biotech Ltd. | -14.13 Million USD | -1529.481% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -869.759% |
| scPharmaceuticals Inc. | -6.54 Million USD | -3419.878% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1280.145% |
| HilleVax, Inc. | -165.48 Million USD | -39.213% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -8977.069% |
| Tharimmune, Inc. | -10.93 Million USD | -2006.709% |
| Genprex, Inc. | -6.73 Million USD | -3319.244% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 37.535% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -160.43% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -16343.683% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -6845.425% |
| OKYO Pharma Limited | -826.84 Thousand USD | -27761.953% |
| Savara Inc. | 153 Thousand USD | 150672.549% |
| Curis, Inc. | -23.88 Million USD | -864.441% |
| Daré Bioscience, Inc. | -5.15 Million USD | -4366.459% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -29587.17% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -3610.954% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 19541.013% |
| BeiGene, Ltd. | -2.25 Billion USD | 89.775% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1967.131% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 62.122% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -24.134% |
| Erasca, Inc. | -37.21 Million USD | -519.024% |
| bluebird bio, Inc. | 108.57 Million USD | 312.189% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -17787.821% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 160.826% |
| DBV Technologies S.A. | -126.98 Million USD | -81.418% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -17787.821% |
| Moderna, Inc. | -2.9 Billion USD | 92.075% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -2125.425% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -2019.764% |
| Molecular Templates, Inc. | 707 Thousand USD | 32685.007% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -634.36% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 166.466% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -180.734% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -151.146% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -613.857% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -570.165% |
| MacroGenics, Inc. | -66.98 Million USD | -243.922% |
| RenovoRx, Inc. | -1.17 Million USD | -19539.898% |
| Adicet Bio, Inc. | -138.78 Million USD | -65.992% |
| Prime Medicine, Inc. | -27.94 Million USD | -724.509% |
| Aditxt, Inc. | 18.12 Million USD | 1371.329% |
| Adagene Inc. | -87.62 Million USD | -162.904% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -5430.668% |
| Quantum-Si incorporated | -118.55 Million USD | -94.317% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 739.844% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2982.288% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -374.914% |
| SciSparc Ltd. | -2.06 Million USD | -11056.223% |
| Vericel Corporation | 1.27 Million USD | 18140.407% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1821.129% |
| Minerva Neurosciences, Inc. | 41 Million USD | 661.834% |
| Generation Bio Co. | 31.44 Million USD | 832.562% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -31.37% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -644.999% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 297.59% |
| Invivyd, Inc. | -198.47 Million USD | -16.072% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -155.208% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -9508.255% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -225.436% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -3275.473% |
| 2seventy bio, Inc. | 181.71 Million USD | 226.779% |
| ADMA Biologics, Inc. | 90.06 Million USD | 355.786% |
| Clene Inc. | 3.34 Million USD | 6997.485% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2436.426% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -970.968% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3470.288% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 33.054% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -786.072% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 229.668% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -5530.508% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 4705.678% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -4322.653% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -76.799% |
| Evaxion Biotech A/S | 5.28 Million USD | 4457.534% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -104.655% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -75.494% |
| Trevena, Inc. | 2.25 Million USD | 10302.657% |
| Surrozen, Inc. | -32.66 Million USD | -605.29% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -347.245% |
| Cingulate Inc. | 3.08 Million USD | 7573.23% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -7743.922% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 3305.454% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -2379.5% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -190.428% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -75.255% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -118.279% |
| Clearmind Medicine Inc. | -3.94 Million USD | -5743.196% |
| Kronos Bio, Inc. | -36.05 Million USD | -538.975% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2548.464% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 15899.447% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -324.609% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1698.013% |
| ImmunityBio, Inc. | 618.22 Million USD | 137.264% |
| Korro Bio, Inc. | -132.94 Million USD | -73.289% |
| Kineta, Inc. | -4.54 Million USD | -4973.244% |
| BioVie Inc. | -17.73 Million USD | -1199.185% |
| Codexis, Inc. | -43.27 Million USD | -432.403% |
| Celularity Inc. | 65.19 Million USD | 453.392% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -7169.675% |
| Celcuity Inc. | 6.78 Million USD | 3496.118% |
| Virax Biolabs Group Limited | -3.36 Million USD | -6746.355% |
| Cibus, Inc. | -8.07 Million USD | -2751.894% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -5347.529% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 5141.05% |
| IN8bio, Inc. | -16.38 Million USD | -1305.675% |
| Kodiak Sciences Inc. | -103.87 Million USD | -121.782% |
| Annexon, Inc. | -193.75 Million USD | -18.901% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 640033.333% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1216.51% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -6457.814% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 121.852% |
| Eyenovia, Inc. | 1.25 Million USD | 18402.664% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 956.257% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -7003.793% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -592.923% |
| Arcellx, Inc. | -296.95 Million USD | 22.421% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1081.052% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -291.297% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1011.478% |
| Moolec Science SA | 117.61 Thousand USD | 195971.31% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -499.953% |
| Geron Corporation | 14.76 Million USD | 1660.707% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -507.564% |
| Royalty Pharma plc | 5.65 Billion USD | 104.071% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -62.901% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -3196.066% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -4195.768% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -63.7% |
| Humacyte, Inc. | -22.48 Million USD | -924.531% |
| Structure Therapeutics Inc. | -124.33 Million USD | -85.281% |
| 89bio, Inc. | -289.05 Million USD | 20.3% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -812.669% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -12820.695% |
| Genelux Corporation | -6.89 Million USD | -3239.267% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -641.737% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 375.573% |
| Notable Labs, Ltd. | -9.77 Million USD | -2256.547% |
| Liquidia Corporation | -80.17 Million USD | -187.338% |
| Mustang Bio, Inc. | -3.73 Million USD | -6066.381% |
| Immunovant, Inc. | -635.22 Million USD | 63.733% |
| Quantum-Si incorporated | -118.55 Million USD | -94.317% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1211.637% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -5460.608% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2970.014% |
| Acasti Pharma Inc. | -23 Million USD | -901.417% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -6741.709% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1317.753% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -67.254% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -7292.466% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -936.236% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1140.648% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -36.093% |
| PepGen Inc. | -60.67 Million USD | -279.72% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -902.681% |
| United Therapeutics Corporation | -507.7 Million USD | 54.624% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1104.517% |
| Solid Biosciences Inc. | -47.75 Million USD | -382.463% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -26622.995% |
| Immuneering Corporation | -54.94 Million USD | -319.301% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -5380.591% |
| Silo Pharma, Inc. | -3.52 Million USD | -6436.773% |
| Belite Bio, Inc | -87.27 Million USD | -163.978% |
| XOMA Corporation | -29 Million USD | -694.4% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -225.864% |
| Bionomics Limited | 227 Million USD | 201.483% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -98.118% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -8994.986% |
| uniQure N.V. | -102.95 Million USD | -123.772% |
| Cassava Sciences, Inc. | -121.13 Million USD | -90.18% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -5430.668% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 662.565% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1826.06% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -7345.414% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 217435.849% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -7003.793% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2687.041% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -3006.472% |
| Altimmune, Inc. | -134.48 Million USD | -71.3% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 216.313% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -8994.986% |
| Compugen Ltd. | -12.9 Million USD | -1685.307% |
| Peak Bio, Inc. | 10.34 Million USD | 2327.974% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -81304.947% |
| Benitec Biopharma Inc. | -50.58 Million USD | -355.451% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -120.798% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1272.695% |
| Zura Bio Limited | -99.8 Million USD | -130.824% |
| PolyPid Ltd. | 6.17 Million USD | 3833.809% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 410.815% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1272.695% |
| Instil Bio, Inc. | 75.35 Million USD | 405.709% |
| argenx SE | -2.02 Billion USD | 88.645% |
| Immunome, Inc. | -97.02 Million USD | -137.43% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -924.121% |
| Verona Pharma plc | -220.44 Million USD | -4.506% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -221.113% |
| Shattuck Labs, Inc. | -121.42 Million USD | -89.729% |
| CervoMed Inc. | -7.79 Million USD | -2856.25% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -24.193% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -5168.145% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -74.872% |
| Moolec Science SA | 117.61 Thousand USD | 195971.31% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -9968.982% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1549.053% |
| AnaptysBio, Inc. | -18.15 Million USD | -1169.219% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1169.289% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -227.327% |
| NeurAxis, Inc. | 145.7 Thousand USD | 158216.678% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 2151.068% |
| Lumos Pharma, Inc. | -28.49 Million USD | -708.535% |
| Achilles Therapeutics plc | -126.92 Million USD | -81.507% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -221.113% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -35032.753% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1008.972% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 15899.447% |
| Nutriband Inc. | -251.65 Thousand USD | -91443.649% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1649.115% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2996.452% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 167.718% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1070.617% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 48.516% |
| Palisade Bio, Inc. | -12.06 Million USD | -1809.774% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -64.19% |
| Beam Therapeutics Inc. | -262.72 Million USD | 12.312% |
| Neurogene Inc. | -131.95 Million USD | -74.587% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1155.996% |
| AEON Biopharma, Inc. | -4.88 Million USD | -4620.82% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 38.923% |
| Sesen Bio, Inc. | -112.55 Million USD | -104.682% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -130.699% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -9712.449% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -490.314% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -176.622% |
| Athira Pharma, Inc. | -88.99 Million USD | -158.852% |
| Vaccinex, Inc. | -1.28 Million USD | -17786.335% |
| HCW Biologics Inc. | 2.85 Million USD | 8164.478% |
| XOMA Corporation | -29 Million USD | -694.4% |
| Nektar Therapeutics | 210.24 Million USD | 209.578% |
| Arvinas, Inc. | -313.8 Million USD | 26.585% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 14295.417% |
| Merus N.V. | -192.88 Million USD | -19.438% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 484.056% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -3220.496% |
| Rezolute, Inc. | -68.16 Million USD | -237.953% |
| Clene Inc. | 3.34 Million USD | 6997.485% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1646.993% |
| BeyondSpring Inc. | -13.75 Million USD | -1574.853% |
| Synlogic, Inc. | -6.68 Million USD | -3346.163% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 20415.344% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2624.731% |
| Peak Bio, Inc. | 10.34 Million USD | 2327.974% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -179.515% |
| Krystal Biotech, Inc. | -350.23 Million USD | 34.222% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 285.6% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -36.32% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -7196.975% |
| MannKind Corporation | 143.89 Million USD | 260.096% |
| Ikena Oncology, Inc. | -109.15 Million USD | -111.052% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2942.874% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -596.0% |
| Gossamer Bio, Inc. | 180.35 Million USD | 227.735% |
| CohBar, Inc. | -5.93 Million USD | -3784.445% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -674.425% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 5145.466% |
| Legend Biotech Corporation | -949.39 Million USD | 75.735% |
| Mural Oncology plc | -255.84 Million USD | 9.954% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 815.12% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -4790.544% |
| Disc Medicine, Inc. | -358.28 Million USD | 35.7% |
| Champions Oncology, Inc. | 4.81 Million USD | 4887.531% |
| REGENXBIO Inc. | 54.76 Million USD | 520.64% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -85571.254% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -52.543% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2456.323% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -185.532% |
| Vaxart, Inc. | -8.24 Million USD | -2695.486% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -359.1% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -81.162% |
| Cellectis S.A. | -43.85 Million USD | -425.313% |
| Longeveron Inc. | -2.9 Million USD | -7822.146% |
| Repare Therapeutics Inc. | -107.85 Million USD | -113.592% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 123.79% |
| Inozyme Pharma, Inc. | 12 Million USD | 2019.16% |
| Revolution Medicines, Inc. | -608.2 Million USD | 62.122% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -18629.756% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 13.104% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -53.51% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1372.333% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -31031.892% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 97.591% |
| Denali Therapeutics Inc. | -74.86 Million USD | -207.722% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1821.129% |
| Veru Inc. | 4.77 Million USD | 4919.613% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1948.515% |
| Cingulate Inc. | 3.08 Million USD | 7573.23% |
| Passage Bio, Inc. | 4.58 Million USD | 5124.558% |
| Context Therapeutics Inc. | -14.44 Million USD | -1494.317% |
| Exicure, Inc. | 5.84 Million USD | 4038.725% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -482.199% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1568.205% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -291.656% |
| Nuvalent, Inc. | -335.38 Million USD | 31.31% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 13383.201% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -209.304% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2491.406% |
| OmniAb, Inc. | 9.2 Million USD | 2603.271% |
| Anew Medical, Inc. | 1.43 Million USD | 16182.487% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1506.296% |
| Lipocine Inc. | -4.75 Million USD | -4745.337% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -109.761% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1612.547% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -354.758% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1025.502% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -3327.704% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -249.972% |
| Ocugen, Inc. | -32.52 Million USD | -608.392% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -169.209% |
| Q32 Bio Inc. | -37.94 Million USD | -507.083% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -36584.076% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1602.831% |
| Equillium, Inc. | -22.39 Million USD | -928.832% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -801.033% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -606.095% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -92825.398% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 271.869% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 7303.752% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 70242.278% |
| Dominari Holdings Inc. | 195 Thousand USD | 118241.538% |
| Edesa Biotech, Inc. | -5.26 Million USD | -4274.026% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2483.559% |
| Bio-Techne Corporation | 267.74 Million USD | 186.042% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1321.284% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -95.078% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2641.592% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1721.01% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 6.015% |
| Nkarta, Inc. | 57.29 Million USD | 502.059% |
| BioCardia, Inc. | 212 Thousand USD | 108767.925% |
| Iterum Therapeutics plc | 13.43 Million USD | 1814.362% |